CAMBRIDGE, MA / ACCESS Newswire / May 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an ...

Moderna said on Friday it has filed a marketing application for the review of its updated COVID-19 vaccine with the U.S. Food ...

The Food and Drug Administration is changing how it handles COVID-19 vaccines starting this fall, limiting access to older ...

The Food and Drug Administration is implementing more rigorous standards for administering the COVID-19 vaccine and experts are worried.

Trump administration to restrict COVID vaccines to seniors and high-risk groups, pending more data for everyone else.

The revised version of the vaccine, marketed as Spikevax, follows FDA guidance recommending that this year’s shots target ...

Under the new FDA guidelines, only people 65 and older and others with one or more health risk factors will be able to receive COVID-19 vaccinations. People considered healthy and under the age of 65 ...

The company said the submission for the vaccine, branded as Spikevax, is based on guidance from the FDA, which advised that the shots should be updated to target strains that are a part of JN.1 ...

Bartholomew County health officials said they are taking a wait-and-see approach after the Trump administration said it plans to limit approval for seasonal COVID-19 shots to seniors and others at ...

The Food and Drug Administration (FDA) will require more evidence for what top officials describe as the uniquely American ...

The Centers for Disease Control and Prevention has confirmed multiple cases of the new COVID-19 variant NB.1.8.1 in the ...